Eliem Therapeutics Inc (ELYM)

Nov 04, 2024

Eliem Therapeutics To Acquire Tenet Medicines - Contract Pharma

Nov 04, 2024

Oct 18, 2024

How To Trade (CLYM) - Stock Traders Daily

Oct 18, 2024

Oct 11, 2024

Climb Bio to present kidney disease treatment study - Investing.com India

Oct 11, 2024

Oct 11, 2024

Climb Bio to present kidney disease treatment study By Investing.com - Investing.com UK

Oct 11, 2024

Oct 03, 2024

Eliem Therapeutics Inc [ELYM] Shares Fall -0.97 % on Wednesday - Knox Daily

Oct 03, 2024

Oct 03, 2024

Eliem Therapeutics mounts corporate rebrand after pipeline overhaul, mass layoffs - FiercePharma

Oct 03, 2024

Oct 02, 2024

Eliem Therapeutics rebrands to Climb Bio, shifts focus to immune diseases - Investing.com

Oct 02, 2024

Oct 02, 2024

Eliem Therapeutics Changes Name to Climb Bio - Yahoo Finance

Oct 02, 2024

Oct 02, 2024

Eliem Therapeutics to change corporate name to Climb Bio - TipRanks

Oct 02, 2024

Oct 02, 2024

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. - The Manila Times

Oct 02, 2024

Oct 01, 2024

Healthy Upside Potential: Eliem Therapeutics Inc (ELYM) - SETE News

Oct 01, 2024

Sep 30, 2024

Monitoring Eliem Therapeutics Inc (ELYM) after recent insider movements - Knox Daily

Sep 30, 2024

Sep 30, 2024

Eliem Therapeutics Inc (ELYM) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Sep 30, 2024

Sep 30, 2024

Ratio Analysis: Unpacking Eliem Therapeutics Inc (ELYM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 30, 2024

Sep 30, 2024

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Stock Position Decreased by Driehaus Capital Management LLC - MarketBeat

Sep 30, 2024

Sep 29, 2024

Selling Eliem Therapeutics Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St

Sep 29, 2024

Sep 28, 2024

Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m - Yahoo Finance

Sep 28, 2024

Sep 26, 2024

Eliem Therapeutics Inc (ELYM) can make a big difference with a little luck - SETE News

Sep 26, 2024

Sep 25, 2024

Eliem Therapeutics Inc (ELYM) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Sep 25, 2024

Sep 25, 2024

Affinity Asset Advisors LLC Takes $11.88 Million Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Sep 25, 2024

Sep 24, 2024

Trading (ELYM) With Integrated Risk Controls - Stock Traders Daily

Sep 24, 2024

Sep 24, 2024

500,000 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Acquired by Ally Bridge Group NY LLC - MarketBeat

Sep 24, 2024

Sep 23, 2024

Eliem Therapeutics: Recent Strategic Pipeline Restructuring (NASDAQ:ELYM) - Seeking Alpha

Sep 23, 2024

Sep 23, 2024

Closing Figures: Eliem Therapeutics Inc (ELYM)’s Positive Finish at 8.43, Up 1.81 - The Dwinnex

Sep 23, 2024

Sep 23, 2024

Eliem Therapeutics Inc (ELYM)’s stock price in review: A technical analysis - US Post News

Sep 23, 2024

Sep 21, 2024

Eliem therapeutics executive sells over $9,000 in company stock By Investing.com - Investing.com Australia

Sep 21, 2024

Sep 20, 2024

Eliem therapeutics executive sells over $9,000 in company stock - Investing.com

Sep 20, 2024

Sep 13, 2024

(ELYM) Trading Signals - Stock Traders Daily

Sep 13, 2024

Sep 11, 2024

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - GlobeNewswire

Sep 11, 2024

Sep 06, 2024

Eliem Therapeutics (NASDAQ:ELYM) Trading Up 4.6% - MarketBeat

Sep 06, 2024

Sep 03, 2024

Eliem Therapeutics Inc [ELYM] Investment Appeal on the Rise - Knox Daily

Sep 03, 2024

Aug 30, 2024

ELYM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Aug 30, 2024

Aug 28, 2024

A Guide To The Risks Of Investing In Eliem Therapeutics Inc (ELYM) - Knox Daily

Aug 28, 2024

Aug 28, 2024

Eliem Therapeutics appoints Kaplan as COO; Rampal as SVP, Clinical Development - MSN

Aug 28, 2024

Aug 28, 2024

Eliem Therapeutics announces executive changes, refocuses on autoimmune diseases - Investing.com India

Aug 28, 2024

Aug 27, 2024

Eliem Therapeutics: Executive Changes Amid Strategic Shift - TipRanks

Aug 27, 2024

Aug 26, 2024

Eliem Therapeutics expands executive team with new COO and SVP - Investing.com

Aug 26, 2024

Aug 26, 2024

Eliem Therapeutics appoints new COO Brett Kaplan - Investing.com

Aug 26, 2024

Aug 26, 2024

Eliem Therapeutics appoints new COO Brett Kaplan By Investing.com - Investing.com UK

Aug 26, 2024

Aug 26, 2024

Eliem Therapeutics Names Brett Kaplan as New COO - TipRanks

Aug 26, 2024

Aug 26, 2024

Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire

Aug 26, 2024

Aug 26, 2024

Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire Inc.

Aug 26, 2024

Aug 21, 2024

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024 - MSN

Aug 21, 2024

Aug 18, 2024

(ELYM) Long Term Investment Analysis - Stock Traders Daily

Aug 18, 2024

Aug 17, 2024

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Up 34.0% in July - Defense World

Aug 17, 2024

Aug 14, 2024

Analyzing Eliem Therapeutics Inc (ELYM) After Recent Trading Activity - Knox Daily

Aug 14, 2024

Aug 14, 2024

Eliem Therapeutics Reports Second Quarter Financial Results - ForexTV.com

Aug 14, 2024

Aug 12, 2024

Sciatica Treatment Industry is Expected to Reach Rapid Growth - openPR

Aug 12, 2024

Aug 08, 2024

ELYM’s 2023 Market Dance: Up 124.07% – Time to Invest? - The InvestChronicle

Aug 08, 2024

Aug 08, 2024

Daily Progress: Eliem Therapeutics Inc (ELYM) Drop -15.50, Closing at 6.05 - The Dwinnex

Aug 08, 2024

Aug 07, 2024

Recent Insider Activity Could Benefit Eliem Therapeutics Inc (ELYM) - Knox Daily

Aug 07, 2024